Amed Co., Ltd. logo

Amed Co., Ltd. (7575)

Market Closed
31 Jul, 05:30
TWSE TWSE
NT$
11. 45
0
0%
NT$
- Market Cap
- P/E Ratio
216% Div Yield
296,484 Volume
- Eps
NT$ 11.45
Previous Close
Add Transaction
Day Range
11.45 11.45
Year Range
8.16 32.6
Want to track 7575 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7575 closed Friday higher at NT$11.45, an increase of 0% from Thursday's close, completing a monthly decrease of -36.9146% or -NT$6.7. Over the past 12 months, 7575 stock lost -60.3806%.
The next announced payment will be in In 1 month on Sep 29, 2026 for a total of NT$25.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Amed Co., Ltd. has completed 2 stock splits, with the recent split occurring on Aug 24, 2023.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).

7575 Chart

Amed Co., Ltd. (7575) FAQ

What is the stock price today?

The current price is NT$11.45.

On which exchange is it traded?

Amed Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 7575.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 216%.

What is its market cap?

As of today, no market cap data is available.

Has Amed Co., Ltd. ever had a stock split?

Amed Co., Ltd. had 2 splits and the recent split was on Aug 24, 2023.

Amed Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Keisuke Suzuki CEO
TWSE Exchange
TW0007575B17 ISIN
Japan Country
1,250 Employees
29 Sep 2026 Last Dividend
27 Dec 2017 Last Split
- IPO Date

Overview

Japan Lifeline Co., Ltd. is a pioneering medical device company established in 1981, with its headquarters situated in Tokyo, Japan. The company is deeply invested in the development, production, importation, distribution, and trading of a wide variety of medical devices, with a special focus on those meant for cardiovascular care. Known for its innovative approach in the medical field, Japan Lifeline Co., Ltd. has built a reputation for delivering high-quality, reliable heart-related medical solutions across Japan, catering to the intricate needs of patients and healthcare providers in the cardiovascular domain.

Products and Services

  • Cardiac Rhythm Management Products:

    These include a range of devices designed to manage heart rhythm disorders effectively. The product lineup features cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices. Each device plays a critical role in offering lifesaving treatments for patients with arrhythmias and other heart rhythm disorders.

  • Electrophysiology/Ablation Products:

    This category encompasses electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. These products are essential for diagnosing and treating heart rhythm conditions with precision and efficacy.

  • Cardiovascular and Endografting Products:

    The product range includes vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems. These are vital for treating various blood vessel conditions and are indispensable in surgeries to repair damaged or weakened areas in the artery wall.

  • Coronary and Peripheral Intervention Products:

    In this category, the company offers PTCA (Percutaneous Transluminal Coronary Angioplasty) and PTA (Percutaneous Transluminal Angioplasty) guide wires, and PTCA balloon catheters. These devices are crucial for opening narrowed or blocked arteries to restore normal blood flow to the heart and other parts of the body.

  • Gastrointestinal Intervention Products:

    Japan Lifeline Co., Ltd. extends its expertise to the realm of gastrointestinal interventions with products like cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems. These tools are essential for diagnosing and managing gastrointestinal diseases.

  • Structural Heart Disease Intervention Products:

    Including products such as radiofrequency wires and atrial septal defect closure devices. These are indispensable in non-invasive surgeries aimed at correcting structural heart diseases, offering patients safer and less intrusive treatment options.

  • Neurovascular Intervention Products:

    The company also provides solutions for neurovascular interventions. These innovative medical devices play a significant role in treating conditions related to the veins and arteries that supply the brain, further showcasing Japan Lifeline Co., Ltd.'s commitment to addressing a comprehensive range of cardiovascular and related health conditions.

Contact Information

Address: Tennoz Ocean Square
Phone: 81 3 6711 5200